1. Home
  2. TXMD

TXMD

TherapeuticsMD Inc.

Logo TherapeuticsMD Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Founded: N/A Country:
United States
United States
Employees: N/A City: BOCA RATON
Market Cap: 24.0M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 21.7K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.98 EPS Growth: N/A
52 Week Low/High: $1.95 - $4.72 Next Earning Date: 05-13-2024
Revenue: $1,302,000 Revenue Growth: -98.14%
Revenue Growth (this year): 605.07% Revenue Growth (next year): 1.11%

Share on Social Networks: